Background: Postoperative urinary retention (POUR) is a frequent complication after total knee arthroplasty (TKA), contributing to prolonged hospital stays, higher healthcare costs, and an increased risk of urinary tract infections (UTIs) and other postoperative complications. Despite the widespread use of bladder ultrasound to guide catheterization decisions, evidence supporting its superiority over symptom-based monitoring is limited. The UREA trial evaluates whether patients undergoing TKA can be safely monitored for POUR based solely on urinary symptoms, potentially reducing unnecessary catheterizations and resource use. Methods: The UREA study is a randomized clinical open-label single-center trial including 170 patients undergoing elective TKA. Participants are randomized in a 1:1 ratio through a sex-stratified sealed-envelope method into either (1) an ultrasound monitoring group or (2) a symptoms monitoring group. In the ultrasound group, bladder volume is assessed repeatedly with a portable scanner, with catheterization performed at a threshold of 800 mL or upon symptoms. In the symptoms monitoring group, follow-up relies exclusively on patient-reported urinary symptoms, with catheterization performed only if symptoms occur or if no spontaneous urination has occurred by 10 h postoperatively. The primary outcome is the difference in International Prostate Symptom Score (IPSS) between groups at 3 months. Secondary outcomes include IPSS at 12 months, urinary complications, and health-related quality of life assessed with the 15D instrument at 3 and 12 months. Statistical analyses will be performed on an intention-to-treat basis, with adjustments for relevant baseline variables. Discussion: This trial is the first randomized study to compare symptom-based with ultrasound-based monitoring of postoperative urinary retention after TKA. If symptom-based monitoring is found to be safe, it may allow for substantial reductions in unnecessary catheterization, procedural discomfort, infection risk, and resource burden. The findings have the potential to inform future clinical guidelines and promote more efficient, patient-centered postoperative care.
Objective:To examine associations of somatic and internalising mental health symptoms with school absences and how experiencing multiple symptoms influences the risk of school absences compared to single symptoms. Methods:The School Health Promotion study is a national survey conducted biennially in Finland by the Finnish Institute of Health and Welfare. We used data collected between 1996 and 2019. Each survey included between 32 439 and 92 227 participants from grades eight and nine (ages 13-17 years). Five somatic symptoms (neck pain, back pain, stomach ache, headache and sleep issues) and symptoms of anxiety and depression were assessed. School absences were reported as excused absences due to an illness and unexcused absences. Results:Somatic symptoms correlated with each other (0.27-0.46), with internalising symptoms (0.20-0.34) and both types of school absences (0.09-0.25). An increasing number of reported somatic symptoms was associated with higher odds for both types of school absences (cumulative OR (COR) 1.73-6.55 for excused and 1.49-4.28 for unexcused absences when students exhibited 1-5 somatic symptoms). Symptoms of depression showed a stronger association with unexcused absences than excused absences (COR 2.37 vs 1.50). Experiencing one somatic symptom or symptoms of anxiety was equally associated with excused and unexcused absences (interaction effect coefficients 0.95 and 0.94, respectively). When both somatic and internalising symptoms were present, COR was highest for excused absences (11.29). Experiencing two somatic symptoms increased the odds of weekly excused absences significantly (OR 9.60). Conclusions:Accumulation of somatic and internalising symptoms is associated with an increased risk of both excused and unexcused school absences. These results warrant multidisciplinary co-operation when planning and implementing interventions for absences.
Abstract Background The Schizophrenia Exome Meta-Analysis (SCHEMA) Consortium has recently identified 40 genes at a false discovery rate <0.05 in which ultra-rare damaging variants substantially increase schizophrenia (SZ) risk. However, the impact of these variants on clinical trajectories across the psychosis spectrum is not yet known. Methods We screened 9,821 sequenced participants with psychotic disorders who passed genomic quality control from the SUPER-Finland psychosis study for ultra-rare variants predicted to be damaging in these 40 SZ-associated genes, identifying 163 variant carriers. To assess the impact of these variants on clinical course and functioning across psychotic disorders, we used five decades of nationwide, full-coverage health register data together with interview, questionnaire, and cognitive assessments collected at study enrollment. We compared the clinical trajectories and functional outcomes of these variant carriers with those of non-carriers, including comparisons across different strata of the schizophrenia polygenic risk score (SZ-PGS) and with participants harboring deleterious variants in other genes associated with neurodevelopmental disorders (NDDs). Results Overall, the variant carriers had a similar distribution of major psychotic disorder diagnoses to that of non-carriers. Despite this diagnostic similarity, variant carriers had earlier hospital admissions than non-carriers for both psychiatric (HR=2.30 [1.48-3.57], p=2.05e-04) and non-psychiatric diagnoses (HR=1.40 [1.10-1.79], p=6.88e-03), indicating increased medical needs early in life. They also showed greater exposure to childhood adversity, lower attainment of adult social milestones, and poorer neuropsychological test performance at study inclusion. Across longitudinal measures, variant carriers showed less favorable clinical and functional trajectories than non-carriers and clustered more closely with individuals with high SZ-PGS (≥90th percentile). Consistent with a liability-threshold model, the variant carriers had lower SZ-PGS than non-carriers among participants with a diagnosis of SZ (β = -0.40, p = 5.32e-05) but higher SZ-PGS than population controls (β = 0.55, p = 9.36e-08), suggesting that the variant carriers developed psychosis at lower levels of common-variant liability. Gene-level analyses identified associations of variants in AKAP11 , SETD1A , and XPO7 with lower SZ-PGS and/or poorer neuropsychological test performance, while carriers of damaging variants in SZ-risk genes also associated with bipolar disorder showed high cumulative burdens of affective disorder diagnoses. Conclusion The disease trajectories of carriers of ultra-rare damaging variants in SZ-risk genes broadly overlapped with those of non-carriers, but carriers showed several differences: greater childhood adversity, earlier hospitalizations, and poorer neuropsychological test performance. These carrier-associated differences were detectable across psychotic disorder diagnoses and suggest a broader phenotypic impact of rare SZ-risk variants than is captured by SZ diagnosis alone, with potential clinical relevance for future risk stratification and genetic counseling.
This study compared standard infrared thermometers used in emergency rooms (ER) and wards to a Zero-Heat-Flux (ZHF) thermometry device and evaluated its feasibility for continuous bedside temperature monitoring. In 60 volunteers, five alternative ZHF sensor placements were assessed against the conventional forehead position (“ZHF-forehead”). Based on these results, continuous ZHF-forehead monitoring was evaluated in 24 hip-fracture patients in an ER (21 patients) and ward (11 patients). Concurrent ZHF and infrared forehead (“IR-forehead”) and ear canal measurements (“IR-ear”) were compared using Bland–Altman analysis (bias, limits of agreement). Among alternative placements, the neck (“ZHF-neck”) showed the closest agreement with ZHF-forehead (0.2, -0.5–0.8 °C). Compared to ZHF-forehead, ZHF-neck did not show improved agreement with either IR-forehead (ZHF-forehead: 0.0, -0.5–0.5 °C vs. ZHF-neck: -0.3, -1.1–0.5 °C) or IR-ear measurements (ZHF-forehead: 0.2, -0.3–0.8 °C vs. ZHF-neck: -0.1, -0.8–0.7 °C). All ER patients showed stable ZHF-forehead temperature profiles, whereas 4 of 11 ward patients had unreliable measurements. Bedside ZHF-forehead measurements in the ER and ward showed moderate agreement with infrared measurements (0.2; -0.4–0.7 °C). In conclusion, ZHF-forehead thermometry showed moderate agreement with point-of-care infrared methods in volunteers and patients, and provided stable continuous bedside temperature measurements in the ER and ward.
Background: Pediatric horizontal distal metaphyseal tibial fractures are relatively uncommon injuries. While nonoperative treatment remains the standard of care for most cases, certain fracture patterns may carry a higher risk of treatment failure, and optimal treatment strategies are still unclear. The aim of this study was to investigate the frequency, anatomical location of these fractures within the metaphysis, and risk factors associated with treatment failure in nonoperative management. Methods: A retrospective, registry-based cohort study was conducted to evaluate treatment success in 86 consecutive pediatric patients with distal metaphyseal horizontal tibial fractures between 2014 and 2023. Demographic, clinical, and radiographic data were analyzed. Logistic regression analysis was performed to identify independent predictors of nonoperative treatment failure. Nonoperative treatment failure was defined as the requirement for cast wedging, re-reduction, or surgical intervention due to loss of reduction or coronal angulation greater than 10° observed on final follow-up radiographs. Results: Of the 86 patients included, 70 (81%) were initially treated non-operatively, while 16 (19%) underwent primary surgical fixation. The overall failure rate in the nonoperative group was 35.3% (25/70). Multivariable logistic regression identified 3 independent predictors of treatment failure: age >11 years (adjusted odds ratio [OR], 10.1; 95% confidence interval [CI], 1.3–81.7; p = 0.030), the presence of a complete fibular fracture (adjusted OR, 6.1; 95% CI, 1.2–30.1; p = 0.027), and initial coronal angulation >10° (adjusted OR, 4.9; 95% CI, 1.1–23.0; p = 0.042). The complication rate was significantly higher in the operative group compared to the nonoperative group (18.3% vs. 4.3%; relative risk, 4.4; 95%CI 1.0–19.7, p = 0.042). Conclusions: Nonoperative treatment remains an effective approach for the majority of pediatric horizontal distal metaphyseal tibial fractures. However, patients with older age, concomitant complete fibular fractures, or marked initial angulation may benefit from early surgical intervention to mitigate the risk of treatment failure. Level of Evidence: IV